Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aprepitant × Breast × Clear all

Phase

Phase 3 4 Phase 4 3 Phase NA 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Breast 1

Conditions

Vomiting 1 Nausea 1 Breast Neoplasms 1

Interventions

Paclitaxel 81 Trastuzumab 68 pembrolizumab 65 Cyclophosphamide 60 Fulvestrant 55 Capecitabine 40 Docetaxel 39 Carboplatin 36 Lapatinib 34 palbociclib 33 Letrozole 33 Doxorubicin 25 Nivolumab 23 olaparib 22 Magnetic Resonance Spectroscopy 22 Taxes 21 Gemcitabine 21 Everolimus 20 Biopsy 19 abemaciclib 18 Specimen Handling 18 Cisplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 18 Ado-Trastuzumab Emtansine 17 ribociclib 16 Radiotherapy 16 pertuzumab 15 fludarabine 15 exemestane 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00719173 2024-11-04

NRR

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡